A phase II study of thymoglobulin in patients with multiple myeloma who are candidates for allogeneic or autologous stem cell transplant

Trial Profile

A phase II study of thymoglobulin in patients with multiple myeloma who are candidates for allogeneic or autologous stem cell transplant

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2011

At a glance

  • Drugs Antithymocyte globulin (Primary)
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Nov 2011 Actual end date (June 2007) added as reported by ClinicalTrials.gov.
    • 10 Jul 2007 Status changed from recruiting to completed.
    • 15 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top